Jagsonpal Pharmaceuticals Financial Statements
Quarterly
Yearly
| Particulars | Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 |
|---|---|---|---|---|---|
| Revenue | 42.84 | 60.00 | 59.49 | 54.47 | 52.14 |
| Expenses | 37.98 | 51.01 | 49.44 | 49.23 | 52.15 |
| EBITDA | 4.86 | 8.99 | 10.05 | 5.24 | -0.01 |
| EBIT | 4.60 | 8.71 | 9.82 | 4.87 | -0.66 |
| Profit Before Tax | 7.38 | 9.71 | 10.27 | 7.14 | 0.20 |
| Net Profit | 5.10 | 6.85 | 7.31 | 5.41 | 0.03 |
| Financial Ratios | |||||
| Operating Profit Margin | 11.32% | 14.98% | 16.89% | 9.62% | -0.04% |
| Net Profit Margin | 11.90% | 11.42% | 12.29% | 9.93% | 0.06% |
| Earning Per Share (Diluted) | 1.94 | 2.61 | 2.79 | 2.06 | 0.01 |
| Dividends Per Share | 1.00 | NA | 4.00 | NA | NA |
